Translations:Lipid-lowering agent/1/en
薬一覧 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| 一般名 | 先発名 | 日本 | 創薬/開発 | 備考 |
|---|---|---|---|---|
| オメガ-3脂肪酸エチルエステル | ロトリガ(武田薬品) (PI) (IF) | 販売 | Takeda Pharmaceutical Company |
Lipid-lowering agents, also sometimes referred to as hypolipidemic agents, cholesterol-lowering drugs, or antihyperlipidemic agents are a diverse group of pharmaceuticals that are used to lower the level of lipids and lipoproteins such as cholesterol, in the blood (hyperlipidemia). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'.